ZWI Therapeutics
October 17, 2023
Franciscan B
Oncology
ZWI Therapeutics is a biotechnology company developing novel protein therapeutics linked to a novel polymer. The company’s proprietary polymer technology reduces the immunogenicity of therapeutic proteins and significantly improves the pharmacokinetics of the protein. ZWI has optimized the novel polymer and begun preclinical development of protein-based therapeutics using the polymer and demonstrating reduced immunogenicity.
Speakers
Company Type
Privately Funded
Website
https://zwitx.com/
CEO/Top Company Official
Ed Mascioli
Lead Product in Development
Uricase linked to a novel polymer
Number Of Unlicensed Products
Multiple as we are a product and platform company
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)